Document is current

Any future updates will be listed below

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

Crossref DOI link: https://doi.org/10.1038/npp.2015.176

Published Online: 2015-06-19

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark